Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1.
about
Growth in North American white children with neurofibromatosis 1 (NF1)Pediatric anterior visual pathway gliomas: trends in fluid and electrolyte dynamics and their management nuances.Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.Boys with precocious or early puberty: incidence of pathological brain magnetic resonance imaging findings and factors related to newly developed brain lesionsManagement and outcome of central precocious puberty.Neurofibromatosis 1: clinical review and exceptions to the rules.Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patientGrowth Hormone Deficiency in a Child with Neurofibromatosis-Noonan SyndromeHeight assessments in children with neurofibromatosis type 1.Sella turcica measurements on lateral cephalograms of patients with neurofibromatosis type 1.Etiology of central precocious puberty in males: the results of the Italian Study Group for Physiopathology of Puberty.Clinical and Genetic Risk Prediction of Subsequent CNS Tumors in Survivors of Childhood Cancer: A Report From the COG ALTE03N1 Study.Optic pathway gliomas in children with and without neurofibromatosis 1.Opticochiasmatic apoplexy in a five-year-old.MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis.Growth hormone excess in children with neurofibromatosis type-1 and optic glioma.
P2860
Q30443016-E8DDF278-0738-46DA-86D9-0AC650FB5B3AQ30882196-B75DCB15-B7EC-4553-88A5-D03EB9974782Q33570283-B104DEBE-0067-44F1-88D3-E752CDB48387Q33635272-6D81FA05-0725-462D-84A0-3E3B80715063Q34549875-2DFCB28C-20F7-4364-9CA7-A9C70301E27CQ34982060-596C977A-1D53-41D8-9F6F-2C065236E4F7Q35182111-E7AC8103-3727-43FC-B957-2C8E847F042EQ36722062-0E05CA0E-F17B-4C89-90D1-6926812E046CQ37627159-6B768703-F3EB-4DEE-8DB6-8903DFFC6EB3Q37721489-7A5621C9-27DB-4278-8C19-381686718285Q42492783-1CA38BF1-D06A-411B-A8E7-79D6FD75FAEDQ46461584-843DD8ED-335B-41EA-9010-D9365BC5B929Q48217326-C9963D08-1368-4113-A089-4D0937668513Q48594062-704168B9-0516-4A6B-85B2-EDE1F15B08D2Q48966894-CBEA5359-BCFB-4801-9AE0-9BFF499F4DB5Q52090885-E86C7F4B-3B38-44C5-B477-EE3CF5C00AE8
P2860
Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Endocrinologic disorders and o ...... with neurofibromatosis type 1.
@en
type
label
Endocrinologic disorders and o ...... with neurofibromatosis type 1.
@en
prefLabel
Endocrinologic disorders and o ...... with neurofibromatosis type 1.
@en
P2093
P356
P1433
P1476
Endocrinologic disorders and o ...... with neurofibromatosis type 1.
@en
P2093
Cnossen MH
Cooiman LC
Niermeijer MF
Simonsz HJ
de Goede-Bolder A
de Muinck Keizer-Schrama SM
P304
P356
10.1542/PEDS.100.4.667
P407
P577
1997-10-01T00:00:00Z